Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced the publication of a peer-reviewed study evaluating the use of ...
A hemorrhage turns time into the enemy: each second of uncontrolled bleeding can push the body closer to shock, organ failure ...
Emergency haemorrhage control encompasses a spectrum of interventions from basic manual compression through advanced endovascular occlusion, all aimed at rapidly arresting bleeding and preserving ...
An evolution of resuscitative, endovascular balloon occlusion of the aorta (REBOA) technology used to manage bleeding in trauma patients could offer much-needed quicker and safer bleeding control in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results